» Articles » PMID: 39077736

Coexistence of a Novel NDM-1-encoding MDR Plasmid and an IMP-4-encoding IncN-IncU Hybrid Plasmid in a Clinical Isolate of BC73

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 Jul 30
PMID 39077736
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the genetic characteristics and transmission mechanism of the NDM-1-, IMP-4-, and SHV-12-producing multidrug-resistant (MDR) clinical isolate, BC73.

Methods: BC73 was isolated from a urine specimen of a urological patient diagnosed with bladder cancer at a Chinese teaching hospital. Antimicrobial susceptibility testing was carried out using DL-120E susceptibility cards and DL-96A system. Whole genome sequencing (WGS) of the isolate was performed using the Illumina and Oxford Nanopore platforms to analyze the genetic context of drug resistance genes and plasmid characteristics. The phylogenetic tree was constructed and visualized by KSNP3.0 software and iTOL5.0 online database.

Results: isolate BC73 co-carrying , and were multidrug-resistant. and were located on a novel IncFIB-like plasmid, pCFBC1, and an IncN-IncU hybrid plasmid, pCFBC2, respectively. The transferability of and from BC73 to J53 was successfully demonstrated. The genetic context of the and genes were IS------ - -∆IS-IS3000 and - ---IS, respectively. Additionally, two extensive transposition units (MGE1 in pCFBC1, MGE2 in pCFBC2) were identified and numerous antimicrobial resistance genes were discovered on it.

Conclusion: To our knowledge, our study represents the first characterization of a ST22 isolate co-harboring , , and , obtained from a urine sample. The dissemination of this MDR isolate should be of close concern in future clinical surveillance.

References
1.
Bodey G . Managing infections in the immunocompromised patient. Clin Infect Dis. 2005; 40 Suppl 4:S239. DOI: 10.1086/427328. View

2.
Wu W, Espedido B, Feng Y, Zong Z . Citrobacter freundii carrying blaKPC-2 and blaNDM-1: characterization by whole genome sequencing. Sci Rep. 2016; 6:30670. PMC: 4964652. DOI: 10.1038/srep30670. View

3.
Guducuoglu H, Gursoy N, Yakupogullari Y, Parlak M, Karasin G, Sunnetcioglu M . Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance. Microb Drug Resist. 2017; 24(7):966-972. DOI: 10.1089/mdr.2017.0173. View

4.
Matsumura Y, Peirano G, Motyl M, Adams M, Chen L, Kreiswirth B . Global Molecular Epidemiology of IMP-Producing Enterobacteriaceae. Antimicrob Agents Chemother. 2017; 61(4). PMC: 5365671. DOI: 10.1128/AAC.02729-16. View

5.
Lalaoui R, Djukovic A, Bakour S, Hadjadj L, Sanz J, Salavert M . Genomic characterization of strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in Spain. Antimicrob Resist Infect Control. 2019; 8:167. PMC: 6820958. DOI: 10.1186/s13756-019-0630-3. View